BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/04/2009

FDA Approves New Dosage for Pfizer's Selamectin Treatment for Kittens

The FDA is updating its regulations to reflect Pfizer's approval of a new dosage for its topical selamectin solution, which will now be suitable for kittens as young as 8 weeks old, following a supplemental application filed by the company.

Source: Federal Register — Food and Drug AdministrationOpen original release →